Maintenance Lurbinectedin in Combination With Serplulimab for Patients With ES-SCLC

"Serplulimab will be administered intravenously at a dose of 4.5 mg/kg on Day 1 of each 21-day cycle for 4 cycles in the induction phase.~Serplulimab will be administered intravenously at a dose of 4.5 mg/kg on Day 1 of each 21-day cycle in the maintenance phase."

Lurbinectedin will be administered intravenously at a fixed dose of 4 mg on Day 1 of each 21-day cycle in the maintenance phase.

Carboplatin will be administered according to the standard of care treatment for 4 cycles in the induction phase.

Etoposide will be administered according to the standard of care treatment for 4 cycles in the induction phase.